ºÚÁÏÍø

Journal of Tuberculosis and Therapeutics
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Awards & Nominations
Publication Policies and Ethics
Useful Links
Related Subjects
View More
Share This Page

Latent Tuberculosis

infection is a condition in which a person is infected with Mycobacterium tuberculosis -complex but does not have active tuberculosis disease. People with latent tuberculosis infection are at risk of progressing to active tuberculosis. Therefore, it is essential that individuals at high risk of progression to active tuberculosis are identified through screening.

Latent Tuberculosis

Expert PPTs

Speaker PPTs

  • Zakaria Hmama
    A non-genetic approach to improve the tuberculosis vaccine BCG
    | PDF Version
  • Hadeel Faisal Gad
    In-vitro analysis of cytokines responses of visceral leishmaniasis and pulmonary tuberculosis patients to homologous and heterologous antigen stimulation
    | PDF Version
  • Rinat Islamov
    Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
    | PDF Version
  • Akujobi Comfort
    Multi drug-resistant tuberculosis (MDR-TB) among HIV positive patients in a tertiary institution in south eastern Nigeria
    | PDF Version
  • Helmi Mardassi
    A ten-year evolution of a multidrug-resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011)
    | PDF Version
  • Takalani Tshitangano
    The management of health care workers’ latent tuberculosis infection at hospitals of Vhembe district
    | PDF Version
  • Abu Salim Mustafa
    Diagnostic potential of M. tuberculosis-specific proteins and peptides
    | PDF Version
  • Syed Khajamohiddin
    Engineering of cytochrome P450 monooxygenases-based novel inhibitors against Mycobacterium tuberculosis
    | PDF Version
Conference Proceedings